Learn to create a GxP compliant Excel spreadsheet application. Understand how to validate Excel spreadsheets with minimal documentation. Learn to configure Excel for audit trails, security features, and data entry verification.
21 CFR Part 11 outlines FDA regulations for electronic records and electronic signatures. It requires that electronic records be trustworthy, reliable, and equivalent to paper records. It also requires that electronic signatures be equivalent to handwritten signatures. The document then outlines the key subparts and sections of 21 CFR Part 11, including requirements for controls on closed and open systems, electronic signature components and controls, and validation of electronic records and signatures.
This document provides an overview of GAMP (Good Automated Manufacturing Practice) guidelines for validation of computer systems used in regulated industries. It discusses the history of GAMP, key terms and concepts in validation like validation life cycle, risk management, categories of software. It also summarizes the validation requirements for different categories of software and records as per GAMP-4 guidelines. The document emphasizes that validation is important to ensure computer systems consistently produce intended results and meet safety standards.
Computer System Validation - The Validation Master PlanWolfgang Kuchinke
Computer System Validation (CSV) is the process used to ensure and document that a computerbased system is operating according to predefined requirements. CSV is necessary when replacing paper records, like
Case Report Forms for clinical trials, with an electronic system within the highly regulated data zone that impacts public health and safety. Necessary validation documents are for example the Standard Operating Procedures (SOPs), which outline how the computer system should be used. Here, we describe in detail the System Validation Master Plan, the most important document in Computer System Validation. In contains topics, like: Validation Policy, Definition of Validation, Rules and Regulations in CSV, Legal basis, FDA 21 CFR Part 11, FDA Guidance for industry, ICH Guideline GCP, Annex 11 EU-GMP, Validation Philosophy, Organisation validation document, Audit Reports, Organisation guidelines, Organisation quality management handbook, etc.
The steps of the Validation Life Cycle are: 1. System Specification, 2. System Classification, 3. Validation Planning, 4. Establishing of the validated state, 5. Maintaining the validated state, 6. System Retirement.
In this slide contains definition, importance, benefits of annual product review.
Presented by: Ravi Sanker babu .D.V (Department of pharmaceutical analysis and quality assurance).
RIPER, anantapur.
The document discusses Good Manufacturing Practices (GMP) guidelines according to ICH Q7A. It states that both GMP and cGMP aim to prevent bad quality products from entering the market. GMP applies to pharmaceutical and healthcare products, while cGMP refers to using the most up-to-date production processes and technologies to comply with regulations, as defined by the FDA. Regulatory agencies that establish GMP standards are mentioned, along with the objectives of GMP and specific guidelines covering quality management, personnel, facilities, equipment, documentation, and production records.
GAMP 5 provides a framework for validating computerized systems used in regulated industries. It recommends a life cycle approach involving quality risk management throughout planning, development, validation and operation. Key activities for regulated companies include governance, identifying systems' impact, and ensuring compliance. Suppliers play an important role by providing documentation, testing systems, and supporting changes and maintenance. The level of validation should be based on a system's risk, complexity and novelty.
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
The use of animals in research is currently an essential component of the drug discovery process.
Animals help us advance our scientific understanding, serve as models to study disease, help us develop and test potential new medicines and therapies.
Animal testing has benefited researchers in understanding how to treat and prevent various conditions such as high blood pressure, diabetes, tuberculosis, polio, muscular dystrophy, and Parkinson's disease.
Education:
Undergraduate teaching to demonstrate effects of various drugs although this has been phased out in most institutes.
Postgraduate teaching to demonstrate the effects of various drugs, to determine the nature of an unknown drug for bioassay, screening methods and to learn skills e.g. administering drugs.
Research:
A larger number and a greater variety of animals are used in pure research than in applied research. This usually involves studies on embryogenesis, developmental biology, behaviour and breeding in Fruit flies, nematodes, mice and rats.
INTRODUCTION
The motto of Prevention of Cruelty to Animals (PCA) Act 1960 as amended in 1982 is to prevent infliction of unnecessary pain or suffering on animals.
The Central Government has constituted a Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), which is duty bound to take all such measures as may be necessary to ensure that animals are not subjected to unnecessary pain or suffering before, during or after the performance of experiments on them.
The goal of these guidelines is to promote the human care of animal used in biomedical and behavioural research and testing.
To avoid/minimize pain and suffering inflicted on experimental animals
Inspection of animal house facilities
It provides guidelines for -
Proper care, housing, breeding, maintenance, handling and use of experimental animals.
Source of experimental animals
Acceptable experimental procedures for anaesthesia and euthanasia.
Registration of establishments conducting animal experimentation or breeding of animals for this purpose.
Selection and assignment of nominees for the Institutional Animal Ethics Committees (IAEC) of the registered establishments.
Approval of Animal House Facilities on the basis of reports of inspections conducted by CPCSEA.
Permission for conducting experiments involving use of animals.
Recommendation for import of animals for use in experiments.
Action against establishments in case of established violation of any legal norm/stipulation.
Conduct of Training Programmes for the Nominees of CPCSEA.
Conduct/Support of Conference/Workshop on Animal Ethics.
To assure quality maintenance and safety of animals used in laboratory studies while conducting biomedical and behavioural research and testing of products.
Quarantine
2. Personal hygiene
3. Environment
4. Physical facility
5. Animal husbandry
6. Animal disposal
7. Documentation
21 CFR Part 11 outlines FDA regulations for electronic records and electronic signatures. It requires that electronic records be trustworthy, reliable, and equivalent to paper records. It also requires that electronic signatures be equivalent to handwritten signatures. The document then outlines the key subparts and sections of 21 CFR Part 11, including requirements for controls on closed and open systems, electronic signature components and controls, and validation of electronic records and signatures.
This document provides an overview of GAMP (Good Automated Manufacturing Practice) guidelines for validation of computer systems used in regulated industries. It discusses the history of GAMP, key terms and concepts in validation like validation life cycle, risk management, categories of software. It also summarizes the validation requirements for different categories of software and records as per GAMP-4 guidelines. The document emphasizes that validation is important to ensure computer systems consistently produce intended results and meet safety standards.
Computer System Validation - The Validation Master PlanWolfgang Kuchinke
Computer System Validation (CSV) is the process used to ensure and document that a computerbased system is operating according to predefined requirements. CSV is necessary when replacing paper records, like
Case Report Forms for clinical trials, with an electronic system within the highly regulated data zone that impacts public health and safety. Necessary validation documents are for example the Standard Operating Procedures (SOPs), which outline how the computer system should be used. Here, we describe in detail the System Validation Master Plan, the most important document in Computer System Validation. In contains topics, like: Validation Policy, Definition of Validation, Rules and Regulations in CSV, Legal basis, FDA 21 CFR Part 11, FDA Guidance for industry, ICH Guideline GCP, Annex 11 EU-GMP, Validation Philosophy, Organisation validation document, Audit Reports, Organisation guidelines, Organisation quality management handbook, etc.
The steps of the Validation Life Cycle are: 1. System Specification, 2. System Classification, 3. Validation Planning, 4. Establishing of the validated state, 5. Maintaining the validated state, 6. System Retirement.
In this slide contains definition, importance, benefits of annual product review.
Presented by: Ravi Sanker babu .D.V (Department of pharmaceutical analysis and quality assurance).
RIPER, anantapur.
The document discusses Good Manufacturing Practices (GMP) guidelines according to ICH Q7A. It states that both GMP and cGMP aim to prevent bad quality products from entering the market. GMP applies to pharmaceutical and healthcare products, while cGMP refers to using the most up-to-date production processes and technologies to comply with regulations, as defined by the FDA. Regulatory agencies that establish GMP standards are mentioned, along with the objectives of GMP and specific guidelines covering quality management, personnel, facilities, equipment, documentation, and production records.
GAMP 5 provides a framework for validating computerized systems used in regulated industries. It recommends a life cycle approach involving quality risk management throughout planning, development, validation and operation. Key activities for regulated companies include governance, identifying systems' impact, and ensuring compliance. Suppliers play an important role by providing documentation, testing systems, and supporting changes and maintenance. The level of validation should be based on a system's risk, complexity and novelty.
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
The use of animals in research is currently an essential component of the drug discovery process.
Animals help us advance our scientific understanding, serve as models to study disease, help us develop and test potential new medicines and therapies.
Animal testing has benefited researchers in understanding how to treat and prevent various conditions such as high blood pressure, diabetes, tuberculosis, polio, muscular dystrophy, and Parkinson's disease.
Education:
Undergraduate teaching to demonstrate effects of various drugs although this has been phased out in most institutes.
Postgraduate teaching to demonstrate the effects of various drugs, to determine the nature of an unknown drug for bioassay, screening methods and to learn skills e.g. administering drugs.
Research:
A larger number and a greater variety of animals are used in pure research than in applied research. This usually involves studies on embryogenesis, developmental biology, behaviour and breeding in Fruit flies, nematodes, mice and rats.
INTRODUCTION
The motto of Prevention of Cruelty to Animals (PCA) Act 1960 as amended in 1982 is to prevent infliction of unnecessary pain or suffering on animals.
The Central Government has constituted a Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), which is duty bound to take all such measures as may be necessary to ensure that animals are not subjected to unnecessary pain or suffering before, during or after the performance of experiments on them.
The goal of these guidelines is to promote the human care of animal used in biomedical and behavioural research and testing.
To avoid/minimize pain and suffering inflicted on experimental animals
Inspection of animal house facilities
It provides guidelines for -
Proper care, housing, breeding, maintenance, handling and use of experimental animals.
Source of experimental animals
Acceptable experimental procedures for anaesthesia and euthanasia.
Registration of establishments conducting animal experimentation or breeding of animals for this purpose.
Selection and assignment of nominees for the Institutional Animal Ethics Committees (IAEC) of the registered establishments.
Approval of Animal House Facilities on the basis of reports of inspections conducted by CPCSEA.
Permission for conducting experiments involving use of animals.
Recommendation for import of animals for use in experiments.
Action against establishments in case of established violation of any legal norm/stipulation.
Conduct of Training Programmes for the Nominees of CPCSEA.
Conduct/Support of Conference/Workshop on Animal Ethics.
To assure quality maintenance and safety of animals used in laboratory studies while conducting biomedical and behavioural research and testing of products.
Quarantine
2. Personal hygiene
3. Environment
4. Physical facility
5. Animal husbandry
6. Animal disposal
7. Documentation
This document provides definitions and information related to computer system validation (CSV) concepts in the pharmaceutical industry. It defines key terms like CSV, data integrity, GxP compliance, regulations, guidelines, directives, and regulatory bodies. These include the US FDA, CDSCO, EMA, PIC/S, ICH, and WHO. The document also explains concepts such as regulatory affairs, computerized systems, validation, verification, qualification, and documentation like the user requirements specification and validation plan. It provides high-level overviews of documentation standards, processes, and quality practices for pharmaceutical computer systems.
An introduction to Life Sciences Computer System Validation, applicable regulation, SDLC phases, software categorisation, risk/ change/ deviation management, validation deliverable, risk based approach, regulatory inspection, audit findings, causes of compliance failure, key concepts in CSV etc.
The document discusses batch production record (BPR) review and release. It defines key terms like deviations, critical process parameters, critical quality attributes. It outlines regulatory requirements from ICH Q7, CFR 211, and consequences of non-compliance. The objectives of BPR review are to confirm the batch quality and was produced under control. Records of critical steps must be reviewed and approved by quality before release. Failure to comply with cGMPs can render a drug adulterated under the FDA act.
The document provides guidance on conducting Annual Product Reviews (APRs), including:
- APRs are required annually for commercial products to verify consistency, assess trends, determine specification/process changes, and evaluate revalidation needs.
- APRs must include review of batches manufactured, deviations, complaints, recalls, changes, specifications, validation status, and trend analyses. Additional requirements may apply from local regulations.
- The review concludes if the product consistently meets quality attributes and necessary corrective actions. APRs communicate between manufacturing, quality, and regulatory to enable quality improvement.
What is 21 CFR Part 11?:
21 CFR Part 11:
Allow the industry to use electronic records and signatures alternatively to paper records and hand-written signatures
21 CFR Part 11 applies:
To all FDA regulated environments
When using computers in the creation, modification, archiving, retrieval or transmission of data or records
To records required by predicate rules – GLP, GCP, GMP – that impact patient safety
To new and old systems
Purpose of Part 11
Ensure data is not corrupted or lost
Data is secure
Approvals cannot be repudiated
Changes to data can be traced
Attempts to falsify records are made difficult and can be detected
Types of Systems
Two types of systems that come under 21 CFR Part 11 – closed and open systems
Closed and Open Systems:
What is a Closed system?
A system to which access is controlled by person responsible for electronic records stored on it
What is an Open system?
A system to which access is not controlled by those responsible for the electronic records stored on it
21 CFR Part 11 Requirements:
21 CFR Part 11 lists the following controls for closed systems:
Validation
Device checks
Operational system checks
Accurate and complete copies
Accurate and steady retrieval
Limited access to systems and data
Authority checks
Electronic audit trail
Training/qualification of personnel
Accountability of signatures
Control over system documentation
Digital Signatures :
Use of digital signatures for open systems
Electronic Signatures
Requirements for signed electronic records
Linking records to signatures
GxP is a general abbreviation for the "good practice" quality guidelines and regulations. These slides provide an overview of current regulations, with a focus on pharmaceuticals and healthcare.
This document covers most of the topics in the CSV like Importance of CVS, Why to perform CSV, Validation Deliverables, Part 11 and Annex 11 Diferences
This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.
Several approaches to software validation exist and may be appropriate for a specific project.
The scope of any validation effort depends upon a number of factors
Size and complexity of the software,
Origin of the software (custom vs. off-the-shelf) and
Whether the functions are critical or non-critical in nature.
By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements.
This document provides guidance on preparing for an FDA pre-approval inspection. It discusses what to expect during an inspection, including that inspectors will review documentation for compliance with quality standards. It stresses the importance of managing the inspection through preparation, including conducting internal audits and training personnel. It also recommends designating an inspection team to guide the process and handle document requests. The overall goal is to demonstrate control over quality issues to avoid delays in approval.
The document discusses Good Automated Manufacturing Practice (GAMP), which are guidelines for manufacturers and users of automated systems in the pharmaceutical industry published by the International Society for Pharmaceutical Engineering (ISPE). GAMP aims to ensure pharmaceutical products have the required quality by establishing principles and procedures for validating automated systems. Key aspects of GAMP covered in the document include focusing on building quality into each stage of manufacturing rather than testing it in, covering all production aspects from raw materials to staff training. The document also summarizes the GAMP5 guidelines released in 2008, which provide a framework for validating computerized systems to ensure they are fit for use and compliant with regulations. GAMP5 emphasizes product and process understanding, a lifecycle approach,
This document discusses Good Laboratory Practices (GLP), which are regulations created by the FDA in 1978 to ensure quality and integrity in nonclinical laboratory studies. It establishes standards for laboratory organization and management, personnel, facilities, equipment, testing operations, and recordkeeping. Key aspects include requiring standard operating procedures, designated study directors, quality assurance units to conduct inspections, maintaining facilities and equipment, ensuring personnel qualifications, and properly housing, caring for, and identifying laboratory animals. GLP aims to eliminate fraudulent activities and poor practices identified in investigations of laboratories in the 1970s.
Computer system validation review article by-mahesh b wazadeMahesh B. Wazade
Computer system validation (CSV) is the process of documenting that a computer system meets defined system requirements. It ensures computerized systems perform as intended in a consistent manner. CSV is important for regulated industries like pharmaceuticals where computer systems are used for quality control and record-keeping. Regulations like 21 CFR Part 11 require electronic records to be validated. CSV enhances reliability and reduces errors and risks to integrity.
The document discusses data integrity and recent regulatory approaches. It defines data integrity as the completeness, consistency, and accuracy of data throughout its lifecycle. Regulatory agencies are increasingly focused on data integrity due to its importance in ensuring product quality and safety. Common data integrity issues found by agencies include fabricated, falsified, or missing records. Ensuring data integrity requires effective quality management systems, risk management, technology solutions, and governance.
The document discusses the MOD, which is an abbreviation that stands for Ministry of Defence in the United Kingdom. The MOD is responsible for implementing the defence policy set by Her Majesty's Government and the defence of the UK and overseas territories. It is the largest government department, employing over 100,000 full-time personnel and is responsible for defence policy, procurement, and the Armed Forces of the UK.
21 cfr part 11 an approach towards compliancedeepak mishra
This document provides an overview of 21 CFR Part 11, which establishes criteria for electronic records and electronic signatures. It discusses the history and meaning of 21 CFR Part 11, key requirements including validation, electronic signatures, controls for closed and open systems. It also defines important terminology, compares 21 CFR Part 11 to Annexure 11, and discusses applicability and the electronic data lifecycle. The document is intended to help organizations understand and comply with 21 CFR Part 11 requirements.
Quality assurance and good manufacturing practices are important to ensure drug quality and safety. Quality assurance covers all factors that influence a product's quality and requires adequate resources. Good manufacturing practices provide quality standards for production and controls to ensure products meet their intended use as required by regulations. Key elements of good manufacturing practices include facilities, equipment, documentation, materials management, production controls, packaging and labeling, storage, and validation. While GMPs vary between countries, the overall goals are similar in requiring design and maintenance standards, standard operating procedures, quality control, trained personnel, and management oversight.
This document discusses the importance of validating Excel spreadsheets. It notes that validated spreadsheets save review time by ensuring calculations are done consistently each time. Only data entry cells would need verification in a validated spreadsheet. Special care must be taken to validate spreadsheets, check formulas and functions used, and address significant digits and rounding rules, especially for medical or regulatory purposes. Spreadsheet validation is important beyond just ensuring accurate calculations, but also evaluates the impact of any software changes.
21CFR regulations & its applicability in the industry and FDA perspective on the same and FDA check points on 21CFR regulations during their inspection.
This document provides definitions and information related to computer system validation (CSV) concepts in the pharmaceutical industry. It defines key terms like CSV, data integrity, GxP compliance, regulations, guidelines, directives, and regulatory bodies. These include the US FDA, CDSCO, EMA, PIC/S, ICH, and WHO. The document also explains concepts such as regulatory affairs, computerized systems, validation, verification, qualification, and documentation like the user requirements specification and validation plan. It provides high-level overviews of documentation standards, processes, and quality practices for pharmaceutical computer systems.
An introduction to Life Sciences Computer System Validation, applicable regulation, SDLC phases, software categorisation, risk/ change/ deviation management, validation deliverable, risk based approach, regulatory inspection, audit findings, causes of compliance failure, key concepts in CSV etc.
The document discusses batch production record (BPR) review and release. It defines key terms like deviations, critical process parameters, critical quality attributes. It outlines regulatory requirements from ICH Q7, CFR 211, and consequences of non-compliance. The objectives of BPR review are to confirm the batch quality and was produced under control. Records of critical steps must be reviewed and approved by quality before release. Failure to comply with cGMPs can render a drug adulterated under the FDA act.
The document provides guidance on conducting Annual Product Reviews (APRs), including:
- APRs are required annually for commercial products to verify consistency, assess trends, determine specification/process changes, and evaluate revalidation needs.
- APRs must include review of batches manufactured, deviations, complaints, recalls, changes, specifications, validation status, and trend analyses. Additional requirements may apply from local regulations.
- The review concludes if the product consistently meets quality attributes and necessary corrective actions. APRs communicate between manufacturing, quality, and regulatory to enable quality improvement.
What is 21 CFR Part 11?:
21 CFR Part 11:
Allow the industry to use electronic records and signatures alternatively to paper records and hand-written signatures
21 CFR Part 11 applies:
To all FDA regulated environments
When using computers in the creation, modification, archiving, retrieval or transmission of data or records
To records required by predicate rules – GLP, GCP, GMP – that impact patient safety
To new and old systems
Purpose of Part 11
Ensure data is not corrupted or lost
Data is secure
Approvals cannot be repudiated
Changes to data can be traced
Attempts to falsify records are made difficult and can be detected
Types of Systems
Two types of systems that come under 21 CFR Part 11 – closed and open systems
Closed and Open Systems:
What is a Closed system?
A system to which access is controlled by person responsible for electronic records stored on it
What is an Open system?
A system to which access is not controlled by those responsible for the electronic records stored on it
21 CFR Part 11 Requirements:
21 CFR Part 11 lists the following controls for closed systems:
Validation
Device checks
Operational system checks
Accurate and complete copies
Accurate and steady retrieval
Limited access to systems and data
Authority checks
Electronic audit trail
Training/qualification of personnel
Accountability of signatures
Control over system documentation
Digital Signatures :
Use of digital signatures for open systems
Electronic Signatures
Requirements for signed electronic records
Linking records to signatures
GxP is a general abbreviation for the "good practice" quality guidelines and regulations. These slides provide an overview of current regulations, with a focus on pharmaceuticals and healthcare.
This document covers most of the topics in the CSV like Importance of CVS, Why to perform CSV, Validation Deliverables, Part 11 and Annex 11 Diferences
This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.
Several approaches to software validation exist and may be appropriate for a specific project.
The scope of any validation effort depends upon a number of factors
Size and complexity of the software,
Origin of the software (custom vs. off-the-shelf) and
Whether the functions are critical or non-critical in nature.
By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements.
This document provides guidance on preparing for an FDA pre-approval inspection. It discusses what to expect during an inspection, including that inspectors will review documentation for compliance with quality standards. It stresses the importance of managing the inspection through preparation, including conducting internal audits and training personnel. It also recommends designating an inspection team to guide the process and handle document requests. The overall goal is to demonstrate control over quality issues to avoid delays in approval.
The document discusses Good Automated Manufacturing Practice (GAMP), which are guidelines for manufacturers and users of automated systems in the pharmaceutical industry published by the International Society for Pharmaceutical Engineering (ISPE). GAMP aims to ensure pharmaceutical products have the required quality by establishing principles and procedures for validating automated systems. Key aspects of GAMP covered in the document include focusing on building quality into each stage of manufacturing rather than testing it in, covering all production aspects from raw materials to staff training. The document also summarizes the GAMP5 guidelines released in 2008, which provide a framework for validating computerized systems to ensure they are fit for use and compliant with regulations. GAMP5 emphasizes product and process understanding, a lifecycle approach,
This document discusses Good Laboratory Practices (GLP), which are regulations created by the FDA in 1978 to ensure quality and integrity in nonclinical laboratory studies. It establishes standards for laboratory organization and management, personnel, facilities, equipment, testing operations, and recordkeeping. Key aspects include requiring standard operating procedures, designated study directors, quality assurance units to conduct inspections, maintaining facilities and equipment, ensuring personnel qualifications, and properly housing, caring for, and identifying laboratory animals. GLP aims to eliminate fraudulent activities and poor practices identified in investigations of laboratories in the 1970s.
Computer system validation review article by-mahesh b wazadeMahesh B. Wazade
Computer system validation (CSV) is the process of documenting that a computer system meets defined system requirements. It ensures computerized systems perform as intended in a consistent manner. CSV is important for regulated industries like pharmaceuticals where computer systems are used for quality control and record-keeping. Regulations like 21 CFR Part 11 require electronic records to be validated. CSV enhances reliability and reduces errors and risks to integrity.
The document discusses data integrity and recent regulatory approaches. It defines data integrity as the completeness, consistency, and accuracy of data throughout its lifecycle. Regulatory agencies are increasingly focused on data integrity due to its importance in ensuring product quality and safety. Common data integrity issues found by agencies include fabricated, falsified, or missing records. Ensuring data integrity requires effective quality management systems, risk management, technology solutions, and governance.
The document discusses the MOD, which is an abbreviation that stands for Ministry of Defence in the United Kingdom. The MOD is responsible for implementing the defence policy set by Her Majesty's Government and the defence of the UK and overseas territories. It is the largest government department, employing over 100,000 full-time personnel and is responsible for defence policy, procurement, and the Armed Forces of the UK.
21 cfr part 11 an approach towards compliancedeepak mishra
This document provides an overview of 21 CFR Part 11, which establishes criteria for electronic records and electronic signatures. It discusses the history and meaning of 21 CFR Part 11, key requirements including validation, electronic signatures, controls for closed and open systems. It also defines important terminology, compares 21 CFR Part 11 to Annexure 11, and discusses applicability and the electronic data lifecycle. The document is intended to help organizations understand and comply with 21 CFR Part 11 requirements.
Quality assurance and good manufacturing practices are important to ensure drug quality and safety. Quality assurance covers all factors that influence a product's quality and requires adequate resources. Good manufacturing practices provide quality standards for production and controls to ensure products meet their intended use as required by regulations. Key elements of good manufacturing practices include facilities, equipment, documentation, materials management, production controls, packaging and labeling, storage, and validation. While GMPs vary between countries, the overall goals are similar in requiring design and maintenance standards, standard operating procedures, quality control, trained personnel, and management oversight.
This document discusses the importance of validating Excel spreadsheets. It notes that validated spreadsheets save review time by ensuring calculations are done consistently each time. Only data entry cells would need verification in a validated spreadsheet. Special care must be taken to validate spreadsheets, check formulas and functions used, and address significant digits and rounding rules, especially for medical or regulatory purposes. Spreadsheet validation is important beyond just ensuring accurate calculations, but also evaluates the impact of any software changes.
21CFR regulations & its applicability in the industry and FDA perspective on the same and FDA check points on 21CFR regulations during their inspection.
This document provides an overview of statistical tools for analyzing binary qualitative data, including process capability using binary intervals, comparisons using Fisher's exact test, paired comparisons using McNemar's test, and modeling using binary logistic regression. It discusses these tools through examples and provides information on their appropriate uses and interpretations.
PPSA is a new act... recently passed in USA.
To monitor the culture between pharma companies and doctors like receiving incentives ,gifts and prescribing those companies drugs
Due to this act , people will be more safer with drugs and healthcare cost burden will reduced...and to know more about act... see the presentration..
Richard Machanoff is an independent IT consultant who provides "Rent a CIO" services to small and mid-sized companies. He has 25 years of experience in IT leadership roles across various sectors. He can help organizations maximize their investment in IT and assist with FDA 21 CFR part 11 compliance. Part 11 permits electronic records and signatures to be equivalent to paper but sets criteria for systems to ensure accuracy, reliability, and security. Compliance requires measures like system validation, audit logs, backups, access controls, and documented processes for systems and personnel. Computer system validation is a key part of the compliance approach.
21 CFR Part 11 Challenges and Solutions - White PaperNextDocs
Many sponsors are concerned with the risks and costs involved in ensuring that their electronic systems comply with the FDA’s ruling on
acceptance of Electronic Records and Electronic Signatures in place of their paper equivalents (21 CFR Part 11). Although the ruling has been in
place since 1997, there is often a lack of clarity concerning what characteristics and features a software solution must have to comply with 21 CFR
Part 11. Even when a solution meets all of its requirements, ensuring that procedural requirements are met may be a bigger challenge.
Although sponsors’ concerns are certainly valid, Part 11 compliance also provides an opportunity. Sponsors and the FDA share a common goal
of ensuring the integrity of their data, documentation and computer systems. If Part 11 compliance can be achieved by software configured to represent the sponsor’s desired business process, the burden on both system users and IT administrators can be minimal. The sponsor can then achieve benefits around both process automation and process transparency. The intent of this paper is to describe how NextDocs products provide a built-in platform for 21 CFR Part 11 compliance while providing capabilities that allow sponsors to automate, monitor and control their processes.
Achieving a 21 CFR Part 11 Compliant eTMFpaulkfenton
The document provides an overview of achieving compliance with 21 CFR Part 11 requirements for an electronic Trial Master File (eTMF). It discusses the history and scope of 21 CFR Part 11, defines electronic records, and outlines the 10 key steps required for an eTMF system to be compliant, including system documentation, ability to generate copies of records, use of electronic signatures, security controls, and training of qualified individuals.
The document discusses corruption, including its definition, types, factors causing it, effects, and measures to curb it. It defines corruption as the abuse of public power for private benefit. Some key points:
- Corruption can take various forms like bribes, fraud, embezzlement, extortion, nepotism.
- Factors that can contribute to corruption include excessive regulations, low wages, lack of transparency, and lack of accountability.
- Corruption negatively impacts economic growth, foreign investment, education and health spending, and inequality.
- Measuring corruption is difficult but methods include perception indexes and estimating unreported economic activity.
- Transparency International publishes an annual Corruption Perceptions Index
21 CFR Part 11 Compliance - Database Integrations dbi_atoms
21 CFR Part 11 presents FDA guidelines for electronic records and electronic signatures in clinical trials. It defines criteria for electronic records and signatures and requires that sponsors and CROs share responsibility for compliance. The guidelines require secure passwords, auditing of electronic signatures, and acknowledgement of the legal standing of electronic signatures. Systems must also prompt re-authentication before electronic signing and store a history of all electronic signatures.
Data Integrity in a GxP-regulated Environment - Pauwels Consulting AcademyPauwels Consulting
On Tuesday, December 6, 2016, our colleague Angelo Rossi, Senior Regulatory Compliance Consultant, gave an interesting presentation about “Data Integrity in a GxP-regulated Environment” at the Brussels Office of Pauwels Consulting in Diegem.
In his presentation, Angelo covered definitions and concepts of data integrity, the change in regulatory focus, lessons learned from recent FDA warning letters, importants highlights of regulations and guidelines. Angelo also presented a practical example of data integrity for a computerized system.
Please contact us at contact@pauwelsconsulting.com or +32 9 324 70 80 if you have any further questions regarding our consulting services in this area.
This document provides an overview of computer validation and compliance with regulatory guidance. It discusses the need for computer validation and outlines key principles from guidance documents such as software validation, use of off-the-shelf software in medical devices, and validation of electronic records and signatures. Validation approaches for different systems and software are covered, including spreadsheets. The document provides references to FDA and international regulatory guidance on these topics.
Gain the latest insight (2013) into 21 CFR Part 11 Compliance from AITalent's latest Webinar.
Discover:
Part 11 – What it is not, the myths.
Part 11 – What it is, the facts.
Part 11 – What does the future hold?
Find out more: www.aitalent.co.uk
Presentation on data integrity in Pharmaceutical IndustrySathish Vemula
Presentation on data integrity in Pharmaceutical Industry
Contents:
- Definition & Basics
- Criteria for integrity of laboratory data
- Regulatory Requirements
- Barriers to Complete Data
- Possible data integrity problems
- Previous observations
- FDA Warning Letters – 2013
- FDA Warning Letters – 2014
- FDA 483’s related to data integrity
- EU – Non compliance Reports
- WHO - Notice of Concern
- Summary of Data Integrity issues
- Consequences- Rebuilding Trust
- Conclusion
The document discusses the FDA's 21 CFR Part 11 regulation on electronic records and signatures. It provides definitions and terminology used in the regulation. The regulation requires three levels of control - administrative, procedural, and technical. It also contains two major subparts on electronic records and electronic signatures. Tables 1 and 2 show how the ComplianceWire system addresses the specific requirements for electronic records and signatures outlined in the two subparts. The purpose is to help FDA-regulated industries quickly and cost-effectively comply with 21 CFR Part 11.
The document discusses the role of Waters Empower Software in assisting companies with 21 CFR Part 11 compliance. 21 CFR Part 11 is the FDA's rule governing electronic records and electronic signatures, which has significant implications for regulated life science industries. The summary discusses how Empower Software provides technical controls to help meet the requirements of 21 CFR Part 11, including accurately archiving and retrieving machine-readable and human-readable data, limiting system access through login credentials, capturing audit trails of user actions, and employing role-based privileges to control system access. Empower Software is presented as a tool to help life science companies achieve compliance with 21 CFR Part 11.
The document discusses the role of Waters Empower Software in assisting companies with 21 CFR Part 11 compliance. 21 CFR Part 11 is the FDA's rule governing electronic records and electronic signatures, which has significant implications for regulated life science industries. The summary discusses how Empower Software provides technical controls to help meet the requirements of 21 CFR Part 11, including accurately archiving and retrieving machine-readable and human-readable data, limiting system access through login credentials, capturing audit trails of user actions, and employing role-based privileges to control system access. Empower Software is presented as a tool to help life science companies achieve compliance with 21 CFR Part 11.
Benefits of Using an EDC System
Contact info@trialjoin.com for more information about patient recruitment help, obtaining new studies or help with site management.
The document provides an overview of computerized system validation. It defines computerized system validation as the process of testing, validating, and qualifying a regulated computerized system to ensure it operates as designed in a consistent and reproducible manner. The document discusses the difference between computer systems and computerized systems, why validation is needed in the pharmaceutical industry, types of validation, applicable regulatory requirements like 21 CFR Part 11, and the GAMP 5 categories for classifying computerized systems. It provides key points about computerized system validation and the V-model approach for validation stages and deliverables.
The 21 CFR Part 11 Compliance Checklist for Digital ApplicationsEMMAIntl
Are digital applications better than paper-based systems? Without a doubt, yes. Applications replace large cabinets of paper storage with a small computer. They not only save space and paper but also offer quick data or document search with easy updates. But there is one component where paper-based systems are better than applications and that is maintaining signatures. Physical signatures cannot be easily replicated. As a software developer, I have successfully developed complex dynamic forms with nested search queries, but it makes me ponder how can I validate a digital record or a signature that would make my developed system as reliable as a paper-based document management system?
This webinar will discuss how to ensure Excel spreadsheets comply with 21 CFR Part 11 requirements for electronic records and electronic signatures. It will cover FDA recommendations for spreadsheet design, development, and maintenance. Attendees will learn how to validate Excel applications, document requirements, and future compliance trends. The webinar leader Angela Bazigos has nearly 30 years of life sciences experience helping companies achieve regulatory compliance.
Streamline data accuracy checks with XLValidator, our advanced Excel validation tool. Detect errors, prevent discrepancies, and enhance spreadsheet reliability. Try it now! For more information, please visit - https://part11solutions.com/excel-validation-tool/
#ExcelValidation
The document discusses validation of computerized systems used in the pharmaceutical industry. It outlines the importance of validation to ensure accuracy, reliability and consistent performance. The key aspects covered include validation protocols, qualification of hardware and software, user requirements, change control, and compliance with regulations like 21 CFR Part 11 and guidance like GAMP 5. The overall goal of validation is to confirm that computer systems meet intended uses and fulfill requirements.
This document provides a checklist for compliance with 21 CFR Part 11, which establishes criteria for electronic records and electronic signatures. It discusses the need for validation, audit trails, electronic signatures, copies of records, and record retention. Each section provides points to evaluate like ensuring limited system access, time-stamped audit trails, unique electronic signatures, and the ability to produce accurate copies of electronic records. The document aims to help organizations evaluate their systems and processes to ensure compliance with FDA regulations for electronic records.
The document discusses the key activities involved in clinical study setup for data management, including designing case report forms (CRFs), developing the study database, programming validation and derivation procedures, and conducting user acceptance testing (UAT). It provides an overview of the study setup process and outlines the objectives, requirements, responsibilities, and deliverables for each setup activity.
1) Clinical trials rely on effective data collection and management systems. Computers have revolutionized these processes by making them timely, reliable and effective.
2) 21 CFR Part 11 provides regulations for computer systems used in clinical trials. It focuses on electronic records, signatures and controls to ensure accuracy, reliability and protect human health.
3) A risk assessment is important to classify computer system risks and ensure compliance with 21 CFR Part 11. This involves analyzing the probability and severity of dangers to determine regulatory requirements.
This webinar discusses an easy-to-implement framework for complying with CFR 21 Part 11 regulations for electronic records in the pharmaceutical industry. The framework provides guidance to identify electronic records that require Part 11 compliance and avoid common compliance issues. It is intended to reduce compliance costs and risks of audit failures for drug manufacturers and software vendors. The webinar covers worksheets for identifying Part 11 elements, a risk-based approach to validation, classifications for validating systems, audit questionnaires, and case studies. It is intended to benefit those involved in quality assurance, manufacturing, validation, and risk management in meeting regulatory requirements for electronic data and records.
Analytical and other equipment should be qualified and computer systems should be validated to demonstrate suitability for the intended use. Electronic records must comply with FDA Part 11 and EU/PICS GMP Annex 11 requirements to ensure data integrity, security and availability.
Calibration, preventative maintenance, Asset Management in Bio-Med Applications. How to comply the FDA validation and Part 11 requirements? computer software for calibration/PM and asset management processes.
To learn about more details, please check out this article.
https://www.qualcy.com/blog/calibration-management-software-asset-management/
SharePoint And 21 CFR Part 11 Share Festpaulkfenton
Presentation given at the ShareFest conference, Philadelphi - April 8th 2010.
This presentation discusses a risk based approach to validation of SharePoint for regulated environments.
GxP is a set of regulations and quality guidelines formulated to ensure the safety of life
sciences products while maintaining the quality of processes throughout every stage of
manufacturing, control, storage, and distribution. The GxP standards were established by the
Food and Drug Administration for a range of compliance related activities and are recognized
as:
G: Stands for good
x: Variable
P: Stands for practices
visit : https://www.agaramtech.com/
Xybion Webinar - Rumors, Risks and Realities of spreadsheet validationXybion Corporation
The document provides an overview of a webinar on spreadsheet validation presented by Xybion Corporation. The webinar discusses common rumors around spreadsheet validation requirements, clarifies the regulatory realities, and outlines the risks of not properly validating spreadsheets used for regulated activities. The presenter explains that while spreadsheets are widely used, regulations still require their validation for intended use to ensure business continuity and data accuracy. Not validating poses risks of regulatory compliance issues. Available software can help address typical spreadsheet deficiencies in security and audit trails.
This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments.
Similar to Excel spreadsheets how to ensure 21 cfr part 11 compliance (20)
This HIPAA Privacy and Security Audits and Enforcement training will cover HIPAA Privacy, Security, and Breach Notification regulations (and the recent changes to them) and how they will be audited. Documentation requirements, enforcement actions and how to prepare and respond to an audit will also be explored.
This document outlines policies and procedures for retail loss prevention. It defines loss prevention as establishing policies to prevent loss of inventory or money. The role of loss prevention is to enhance profitability by reducing shrinkage (inventory losses). Shrinkage refers to missing inventory and can be caused by internal and external theft, paperwork errors, and other issues. The document discusses measuring shrinkage and factors considered. It also covers non-inventory dollar losses. Finally, it emphasizes that loss prevention should be a critical business component and outlines the five key aspects: people, philosophy, policies, procedures, and practices.
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potentialcomplianceonline123
The Clean Power Plan aims to curb carbon dioxide emissions from power plants by paving the way for cleaner energy sources. It establishes state-by-state emission reduction targets to be achieved by 2030 through three building blocks: improving efficiency in coal plants, increasing natural gas use over coal, and bringing more renewable sources online. The smart grid can help reduce greenhouse gas emissions by improving reliability, facilitating renewable integration, enabling distributed energy resources, reducing losses, and promoting conservation through consumer feedback. A webinar on how the smart grid can help reach Clean Power Plan goals at no cost will be held on September 30.
The document defines internal audit as an independent, objective assurance function that helps an organization accomplish its objectives by evaluating risk management and governance processes. It describes three types of audits: first-party audits evaluate an organization against its own standards, second-party audits are performed by customers on suppliers, and third-party audits are external audits performed on suppliers for registration purposes. The audit process involves planning, implementing, monitoring, and improving the audit program. Planning includes establishing objectives, responsibilities, and procedures. Implementation involves scheduling, directing activities, and record keeping. Monitoring reviews and improves the program. Improvement identifies needs for continual enhancement.
The document defines internal audit as an independent, objective function that evaluates risk management, controls and governance to help an organization achieve its objectives. It lists skills like communication, technical expertise, integrity, business acumen and skepticism as important for internal auditors. The document also describes functional and administrative reporting structures and outlines the key components an internal audit charter should include like scope, responsibilities and standards. Finally, it provides an overview of the audit process from planning to closing meetings and recommends training resources on auditing best practices.
What is a Free Trade Zone?
A free trade zone (FTZ)is a designated area that eliminates traditional trade barriers, such as tariffs, some kind of taxes and fees and minimizes bureaucratic
regulations.
The goal of a free trade zone is to enhance global market presence of the Country or location by attracting new business and foreign investments.
Tax-free trade zones generate foreign exchange through exports, and create economic value added.
Free, foreign, and export processing zones all fall under the umbrella of being free trade zones. Because these terms are confusingly similar, they are often used
interchangeably.
What is SEC?
The U.S. Securities and Exchange Commission (SEC) oversees the key participants in the securities world.
Concerned with promoting disclosure of important market information, maintaining fair dealing, and protecting against fraud.
Responsibilities include:
Interpret and enforce federal securities laws
Issue new rules and amend existing rules
Oversee inspection of securities firms, brokers, investment advisers and ratings agencies
Oversee private regulatory organizations in securities, accounting, auditing fields
Coordinate U.S. securities regulation with federal, state, and foreign authorities
SEC Organization:
Division of Corporate Finance:Reviews documents required to be filed with the Commission
Division of Trading: Assists in maintaining fair, orderly and efficient markets.
Division of Investment Management: Maintains oversight of America’s $26T investment management industry
Division of Enforcement: Recommends commencement of investigations of SEC law violations
Division of Economic and Risk Analysis: Integrates robust economic analysis and data analytics
Laws Governing SEC:
Securities Act of 1933
Securities Exchange Act of 1934
Trust Indenture Act of 1939
Investment Company Act of 1940
Investment Advisers Act of 1940
Sarbanes-Oxley Act of 2002
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010
Jumpstart Our Business Startups Act of 2012
SEC Reports:
8k - A report of unscheduled material events or corporate changes at a company that could be of importance to the shareholders or SEC
10k - Comprehensive summary report of a company's performance. Submitted annually to the SEC
10Q - A comprehensive report of a company's performance that must be submitted quarterly by all public companies to SEC. In10-Q, firms are required to disclose relevant information regarding their financial position.
18K - Use to update the SEC and investors regarding the status of a domestically traded foreign security and its issuer.
20F - A form issued by the SEC that must be submitted by all "foreign private issuers" that have listed equity shares on exchanges in the U.S.
SEC Investigations:
Can be triggered in many ways
Investigation is not the same as prosecution
Investigations involve fact finding and are usually not public
During an investigation, neither the staff nor the Commission makes any determination of wrongdoing
Following investigation, SEC staff present findings to the Commission
Commission can authorize the staff to file a case in federal court or bring an administrative action.
What Constitutes a GRC Program?
Governance, risk and compliance or GRC programs are complex – an organization has to use its GRC program to address the regulatory requirements expected of, among
others, the following:
Enterprise Risk Management
COSO Internal Controls
Environmental Compliance (EPA rules)
Anti Trust
Anti Money Laundering
Anti Bribery/Corruption
Quality Management and Standards such as ISO 9000, 9001
Process Management such as Six Sigma
Anti Harassment
Human Capital
Whistle-blowing
HR Processes
The areas listed above are just few of those that come under the purview of a robust GRC program.
Why Audit a GRC Program?
Given the complex nature of regulations around the world today and the increasing risks of doing business, it is important that the GRC program in an organization is
audited frequently. Most of the lapses in corporate governance occur due to outdated GRC programs that have not been audited and updated to reflect the current
regulatory environment.
Internal audits of GRC programs allow management and the board to identify risks and areas that need strengthening and root out any non-compliance.
An audit can help evaluate the adequacy of the program’s design and effectiveness as well as new practices and technologies to be implemented.
Audits of the GRC program have to be carried out periodically – these should supplement an ongoing, daily evaluation of the effectiveness of the program, including
monitoring of controls and responses.
Internal Audit Process – The General Steps:
Define evaluation scope, objectives, and the type of evaluation.
Define the level and type of assurance
Identify the evaluation team and skills required.
Develop evaluation plan.
Perform design adequacy evaluation.
Perform operational effectiveness evaluation.
Communicate evaluation results and ensure follow-up to address issues.
This quick reference guide discusses the anti-money laundering requirements for non-bank financial institutions including for Money Services Business (MSB).
The document defines harassment as unwelcome verbal or physical conduct based on protected characteristics that results in a tangible employment action or creates a hostile work environment. It states harassment can be committed by managers, coworkers, customers, vendors, and others, and can target victims, bystanders, or witnesses. The document provides examples of sexual harassment and advises reviewing anti-harassment policies, complying with anti-discrimination laws, knowing how to respond to issues, and reporting harassment immediately. It recommends online training resources on these topics.
What is Information Security?
Information security means that the confidentiality, integrity and availability of information assets is maintained.
Confidentiality: This means that information is only used by people who are authorized to access it.
Integrity: It ensures that information remains intact and unaltered. Any changes to the information through malicious action, natural disaster, or even a simple innocent mistake are tracked.
Availability: This means that the information is accessible when authorized users need it.
Information Security Threats:
Most common types of information security threats are:
Theft of confidential information by hacking
System sabotage by hackers
Phishing and other social engineering attacks
Virus, spyware and malware
Social Media-the fraud threat
Theft of Confidential Information:
One of the major threat to information security is the theft of confidential data by hacking. This includes theft of employee information or theft of trade secrets and other intellectual property (IP).
Theft of Employee Information
Employee information includes credit card information, corporate credit card information, social security number , address, etc. It also includes theft of healthcare records as they contain personal information such date of birth, address, and name of relatives.
Theft of Trade Secrets and other Intellectual Property (IP)
Technology from various verticals including IT, aerospace, and telecommunications are constantly stolen by outsiders or insiders (industrial espionage). China is a growing offender as it continues to advance in technology relying on theft of international trade secrets and IP.
Piracy/copyright infringement.
Corporate business strategies including marketing strategies, product introduction strategies.
System Sabotage:
What is system sabotage?
Planting malware on networks of target organization and generating an enormous amount of transaction activity resulting in malfunction or crash of the system.
Who would perpetrate it?
System sabotage is usually committed by disgruntled ex-employees and by remote cyber-attackers for no particular reason.
The most sensational case of system sabotage: One of the recent examples is the sabotage of Sony PlayStation.
Phishing:
To obtain confidential data about individuals-customers, clients, employees or vendors that can be used to commit various types of identity fraud such as:
Opening bank accounts in victim’s name
Applying for loans in victim’s name
Applying for credit cards in victim’s name
Obtaining medical services in victims name (e-death)
Other kind of more sophisticated social engineering attacks include spear-phishing.
Spear-phishing targets specific individuals such as AP manger, controller, senior accountant to gain access to corporate bank accounts and transfer funds abroad.
Other threats include:
Smishing: Phishing via SMS (texting)
Vishing: Phishing via voice (phone)
Mobile hackin
This guide details common mistakes made by employees in Section 1 and by employers in Section 2 and Section 3 of the Form I-9 and best practices for avoiding such errors.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
2. What are
Spread-
sheets?
Spreadsheets are a
repository for critical
data, and for making
critical decisions.
In Microsoft Excel,
the workbook is the
file that the user
creates.
Each worksheet
contains -
calculations, data
entry fields, audit
trail, and display
formats that
comprise the
application.
3. FDA Expectations for Use of
Spreadsheets
All spreadsheets containing GxP or quality data must be compliant with 21 CFR 11 and the
data within must be controlled.
21 CFR 11.10: Persons who use closed systems to create, modify, maintain, or transmit
electronic records shall employ procedures and controls designed to ensure the
authenticity, integrity & when appropriate, the confidentiality of electronic records, and to
ensure the signer cannot readily repudiate the signed record as not genuine.
FDA has stepped up 21 CFR 11 enforcement since late 2010.
5. Which Spreadsheets should be
Compliant?
Spreadsheets that control
GxP data
Clinical: Research Data,
Result Data etc
Laboratory: Lab Data,
Animal Data etc
Manufacturing Data
Spreadsheets used to
make quality decisions
Documented evidence of
SOPs
Tracking Logs: Internal
Audits, Approved Supplier
Lists, Approved Batches, etc.
QA: Quality Assurance Data
Spreadsheet containing
data that will be reported
to a Regulatory Agency
Even if it does not fit the
previous 2 requirements
Risk based approaches
apply
6. Best Practices to Comply with
FDA Requirements
Develop,
communicate
and enforce a
company policy
and master
plan for
spreadsheet
calculations.
Prepare an
inventory list
with all
computers that
run
spreadsheets.
Standardize
“development
and use” as
much as
possible.
Protect
spreadsheets
using built-in
standard
software and IT
infrastructure
(e.g.,
client/server).
Validate
spreadsheet
calculations.
Document and
justify your
approach.
7. Want to learn more about 21 CFR Part 11, its requirements and best practices to
comply with them? ComplianceOnline webinars and seminars are a great training
resource. Check out the following links:
• Excel Spreadsheets: Develop and Validate for 21 CFR Part 11 Compliance
• Design and Validation of Excel Spreadsheets: Step-by-Step
• Learning from Recent FDA Warning Letters Related to Part 11
• Understanding and Implementing FDA'S 21 CFR Part 11
• How to Comply with 21 CFR Part 11 Requirements for Electronic Medical Records
• Computerized System Validation - A Detailed Insight
• 21 CFR Part 11: How to Successfully Prepare for and Host an FDA Inspection
• Complying with 21CFR Part 11-Understanding the Role of Predicate Rules